| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/17/2002 | CN1345320A Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands |
| 04/17/2002 | CN1345319A Triazole compounds with dopamine-D3-receptor affinity |
| 04/17/2002 | CN1345318A Triazole compounds with dopamine -D3-receptor affinity |
| 04/17/2002 | CN1345317A (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for production thereof and pharmaceutical compositions containing the same |
| 04/17/2002 | CN1345315A Hydroxymatatairesinol in cancer prevention |
| 04/17/2002 | CN1345311A 1-arenesulfonyl-2-aryl-pyrolidine and piperidine derivatives for treatment of CNS disorders |
| 04/17/2002 | CN1345309A Diaryl derivatives and their use as medicaments |
| 04/17/2002 | CN1345308A Acetylenic alpha-amino acid based sulfonamide hydroxamic acid TACE inhibitors |
| 04/17/2002 | CN1345307A N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists |
| 04/17/2002 | CN1345303A Oxamic acids and derivatives as thyroid receptor ligands |
| 04/17/2002 | CN1345238A Method for treatment of neurological or neuropsychiatric disorders |
| 04/17/2002 | CN1345234A Microencapsulated bovine adrenal medulla chromaffin cell-drug for alleviating pain |
| 04/17/2002 | CN1345213A Transdermal therapeutic system with nicotine and addition of monoterpene ketones |
| 04/17/2002 | CN1345189A Nutritional compositions with contain slightly negatively charged, non-digestible polysaccharides and use thereof for reducing transport through tight junctions |
| 04/17/2002 | CN1344755A Prep. of degradable polymer, pharmaceutical composition containing the same and its use |
| 04/17/2002 | CN1344717A Quaternary ammonium salt compound of piperazine with pain relieving effect |
| 04/17/2002 | CN1344559A Drug addiction stopping medicine 'Zaishengchun' |
| 04/17/2002 | CN1082963C Isoxazolidine derivatives |
| 04/17/2002 | CN1082959C Substituted benzothienylpiperazines, their use as medicaments and processes for their preparation |
| 04/17/2002 | CN1082816C Use of penciclorim for treatment of post-therapeutic neuralgia |
| 04/17/2002 | CN1082815C 吲哚衍生物 Indole derivatives |
| 04/16/2002 | US6372919 (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent |
| 04/16/2002 | US6372777 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/16/2002 | US6372776 Crystalline(−)-3R,4R-trans-7-methoxy-2,2-dimethyl-3-phenyl-4-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}chromane, hydrogen maleate |
| 04/16/2002 | US6372773 Treatment of inflammation, arthritis with urea or thiourea heterocycles |
| 04/16/2002 | US6372770 Benzoxazoles |
| 04/16/2002 | US6372768 2-aminopyridines containing fused ring substituents |
| 04/16/2002 | US6372767 Benzanilides as potassium channel openers |
| 04/16/2002 | US6372762 Heterocyclic compounds for nervous system disorders |
| 04/16/2002 | US6372760 Stabilized composition comprising antidementia medicament |
| 04/16/2002 | US6372758 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 04/16/2002 | US6372757 Phenylurea and phenylthio urea derivatives |
| 04/16/2002 | US6372756 Narcotics or analgesics |
| 04/16/2002 | US6372754 Drugs for treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis or postherpic neuralgia. |
| 04/16/2002 | US6372746 Derivatives of acyl-piperazinyl-pyrimidines, preparation thereof and application as medicaments |
| 04/16/2002 | US6372743 Certain alkylene diamine-substituted pyrazlo (1,5-a)-1,5-pyrimidines and pyrazolo (1,5-a) 1,3,5-triazines |
| 04/16/2002 | US6372740 2-aryl-8-oxodihydropurine derivative, process for the producing the same, medicinal compositions containing the same, and intermediates thereof |
| 04/16/2002 | US6372734 Crystalline dibenzothiazepine derivative and its use as an antipsychotic agent |
| 04/16/2002 | US6372473 Tissue plasminogen activator-like protease |
| 04/16/2002 | US6372462 Cultivating a fungi of the basidiomycetes in a submerged culture on nutrient media, isolating the biomass of edible mushrooms from the culture broth, and drying at a range of 40-45 degrees celsius |
| 04/16/2002 | US6372250 Non-invasive gene targeting to the brain |
| 04/16/2002 | US6372226 Intrathecal administration to a human patient of a neurotoxin such as botulinum toxin type a |
| 04/16/2002 | CA2218552C Benzimidazole compounds and their use as modulators of the gabaa receptor complex |
| 04/16/2002 | CA2217601C Benzimidazole compounds and their use as modulators of the gabaa receptor complex |
| 04/16/2002 | CA2217565C Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 04/16/2002 | CA2143252C Benzodioxanes derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 04/16/2002 | CA2114593C Indole, indazole and benzisoxazole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 04/16/2002 | CA2088980C Pro-drugs for cck antagonists |
| 04/16/2002 | CA2087414C Arylcycloalkyl derivatives their production and their use |
| 04/16/2002 | CA2076948C Isatineoxime derivatives, their preparation and use |
| 04/11/2002 | WO2002029418A1 Selective anxiolytic therapeutic agents |
| 04/11/2002 | WO2002029408A2 Methods for diagnosing and treating huntington's disease |
| 04/11/2002 | WO2002029088A2 Highly expressible genes |
| 04/11/2002 | WO2002029065A2 Retroviral vectors containing internal ribosomal entry sites |
| 04/11/2002 | WO2002029061A2 G-protein coupled receptors |
| 04/11/2002 | WO2002029060A2 Hematopoietin receptors hpr1 and hpr2 |
| 04/11/2002 | WO2002029059A2 Nogo receptor homologs |
| 04/11/2002 | WO2002029058A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | WO2002029055A2 Carbohydrate-associated proteins |
| 04/11/2002 | WO2002029053A1 Novel g protein-coupled receptor protein and dna thereof |
| 04/11/2002 | WO2002029049A2 Regulation of human sodium-dependent monoamine transporter |
| 04/11/2002 | WO2002029044A2 Modulation of the transcription of pro-inflammatory gene products |
| 04/11/2002 | WO2002029038A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | WO2002029036A2 Lipid metabolism enzymes |
| 04/11/2002 | WO2002029014A2 Stem cell differentiation-inducing promoter |
| 04/11/2002 | WO2002028906A2 Regulation of human sphingosine kinase-like protein |
| 04/11/2002 | WO2002028905A2 Human anti-cd40 antibodies |
| 04/11/2002 | WO2002028904A2 Human anti-cd40 antibodies |
| 04/11/2002 | WO2002028897A2 Human g-protein coupled receptor and uses thereof |
| 04/11/2002 | WO2002028889A2 Haemophilus influenzae antigens and corresponding dna fragments |
| 04/11/2002 | WO2002028885A1 N-alkylglycine trimeres capable of protecting neurons against excitotoxic aggressions and compositions containing said trimeres |
| 04/11/2002 | WO2002028867A2 Ethers of 7-desmethylrapamycin for use in immunosuppression |
| 04/11/2002 | WO2002028866A2 Hydroxyesters of 7-desmethylrapamycin |
| 04/11/2002 | WO2002028865A2 Condensed pyridoindole derivatives |
| 04/11/2002 | WO2002028859A2 Condensed pyridoindole derivatives |
| 04/11/2002 | WO2002028858A2 Hexahydropyrazino `1'2' : 1, 6!- pyrido `3, 4-b! indole-1, 4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
| 04/11/2002 | WO2002028856A1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases |
| 04/11/2002 | WO2002028853A1 Benzylamine compound, process for producing the same, and intermediate therefor |
| 04/11/2002 | WO2002028850A1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells |
| 04/11/2002 | WO2002028847A1 New thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors |
| 04/11/2002 | WO2002028839A1 Benzimidazole and indole derivatives as crf receptor modulators |
| 04/11/2002 | WO2002028837A1 Metabotropic glutamate receptor antagonists |
| 04/11/2002 | WO2002028830A1 Novel phenylalanine derivatives |
| 04/11/2002 | WO2002028824A1 Citrullimycines, a process for their production and their use as pharmaceuticals |
| 04/11/2002 | WO2002028817A1 Substituted 1-aminobutan-3-ol derivatives |
| 04/11/2002 | WO2002028816A1 Substituted 5-amino-1-pentene-3-ol derivatives |
| 04/11/2002 | WO2002028815A1 Pharmaceutical compounds |
| 04/11/2002 | WO2002028481A2 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 04/11/2002 | WO2002028480A2 Methods of therapy for b-cell malignancies |
| 04/11/2002 | WO2002028440A1 Methods and compositions for modulating t cell activation and uses thereof |
| 04/11/2002 | WO2002028434A2 Use of a ppar delta activator for treating inflammatory conditions |
| 04/11/2002 | WO2002028433A2 Use of a ppar delta activator in the treatment of diseases related to no inhibit ion or tnf inhibition |
| 04/11/2002 | WO2002028419A2 Chemokine mutants in the treatment of multiple sclerosis |
| 04/11/2002 | WO2002028393A1 Use of neuropeptide-y antagonists in treatment of alcoholism |
| 04/11/2002 | WO2002028392A1 Remedies for brain circulatory disturbances |
| 04/11/2002 | WO2002028383A1 Delivery system for multi-pharmaceutical active materials at various release rates |
| 04/11/2002 | WO2002028377A1 Ihnalation particles incorporating a combination of two or more active ingredients |
| 04/11/2002 | WO2002028347A2 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 04/11/2002 | WO2002028165A2 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/11/2002 | WO2002007766A8 Use of d5-dopamine receptor agonists in the manufacture of a medicament for the treatment of dyskinesia |